VentureBeat made with Google Gemini 3.1 Pro Image The transition from AI as a chatbot to AI as a workforce is no longer a theoretical projection; it has become the primary design philosophy for the ...

Application security posture management company Apiiro Ltd. today announced the launch of Apiiro CLI, a new command-line interface that is designed to bring application security directly into ...

Solana is aiming to attract enterprises and financial institutions to its ecosystem through a new unified developer platform, which is focused on tokenization and stablecoins. Update (March 25, 3:05 ...

Windows development has always been complex, but new insights from a former Microsoft executive shed light on just how fragmented it became. Jeffrey Snover, speaking about the platform’s history, ...

Ever thought what turns a good idea into a working application? The short and simple answer to this question is selecting the right framework. As Python has gained popularity among web development ...

Two men were arrested after a party got out of hand Thursday night in Lockland. Bomb squad called to Greater Cincinnati home for Civil War artifacts The Butler County Sheriff’s Office Bomb Unit was ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

Spotify is changing how its APIs work in Developer Mode, its layer that lets developers test their third-party applications using the audio platform’s APIs. The changes include a mandatory premium ...

CSIS’s Global Development Department is dedicated to strengthening U.S. national security and global prosperity through policies that promote human wellbeing and economic opportunity. Our scholars ...

Members of the Windows 1.0 team at their 40-year reunion this week. L-R, kneeling/sitting: Joe Barello, Ed Mills, Tandy Trower, Mark Cliggett, Steve Ballmer (holding a Windows 1.0 screenshot) and Don ...

The FDA has proposed cutting fees for early-stage companies conducting clinical development in the U.S. instead of abroad. The proposal is designed to incentivize U.S. drug development by tacking on ...